SAN DIEGO, California — July 15, 2026 — MOSkin USA Corporation, a wholly owned subsidiary of Electrogenics Holdings Ltd., today announced two significant commercial milestones that advance the company’s commercialization strategy for its innovative MOSkin™ radiation dosimetry technology.
MOSkin USA Corp. is pleased to announce the appointment of Standard Imaging, Inc. as its exclusive distributor throughout North America. The partnership combines MOSkin’s innovative in-vivo dosimetry technology with Standard Imaging’s extensive commercial organization, established customer relationships, and decades of leadership in radiation oncology quality assurance and dosimetry.
Through this exclusive agreement, Standard Imaging will market, sell, and support the MOSkin product portfolio in the United States providing radiation oncology centers with access to advanced in vivo dosimetry solutions through one of the industry’s most respected organizations. Canada and Mexico will follow, pending regulatory clearances.
Coinciding with this announcement, MOSkin USA Corp. will make its inaugural appearance as an exhibitor at the American Association of Physicists in Medicine (AAPM) Annual Meeting, taking place July 19–21 in Vancouver, British Columbia. The AAPM Annual Meeting is the premier scientific and clinical conference for medical physicists and radiation oncology professionals in North America, bringing together thousands of clinicians, researchers, and industry leaders dedicated to advancing cancer treatment.
At AAPM, MOSkin USA Corp. will showcase its innovative MOSkin dosimetry platform, designed to provide clinicians with accurate, rapid in-vivo dose results that support treatment verification, improved workflows, and improved patient safety during radiation therapy.
“The appointment of Standard Imaging represents a significant milestone in the commercialization of the MOSkin System.” said Bradley Tvedt, Vice President, Commercial, MOSkin USA Corporation. “Their outstanding reputation, deep relationships within the medical physics community, and experienced commercial organization make them an ideal partner as we expand access to MOSkin throughout North America. Our inaugural participation at AAPM provides an excellent opportunity to introduce clinicians and medical physicists to the clinical value of MOSkin technology and the benefits it can bring to patient care.”
“MOSkin USA Corp.’s technology is a valuable addition to the Standard Imaging portfolio and aligns with our mission of helping clinics deliver safe, accurate, and effective radiation therapy,” said Eric DeWerd, MBA, CEO & President of Standard Imaging. “Through this exclusive distribution partnership, we are expanding our patient QA solutions and providing our customers with greater access to innovative tools that enhance clinical confidence and support the highest standards of patient care. We look forward to working together to bring this technology to the medical physics community and help clinics strengthen patient-specific treatment verification and decision-making.”
Attendees of the AAPM Annual Meeting are invited to visit the MOSkin USA Corp. exhibit to learn more about the company’s innovative dosimetry technology and discuss how the MOSkin System can enhance radiation dose verification, quality assurance, and patient safety in radiation oncology.
About MOSkin USA Corporation
MOSkin USA Corporation is a wholly owned subsidiary of Electrogenics Holdings Ltd. focused on commercializing advanced MOSkin radiation dosimetry technologies throughout North America. MOSkin technology provides accurate, rapid in vivo dose results that help clinicians verify radiation delivery, strengthen quality assurance, and enhance patient safety during radiation therapy.
About Electrogenics Holdings Ltd.
Electrogenics Holdings Ltd. develops advanced semiconductor-based radiation sensing technologies for medical applications. Through its proprietary MOSkin platform, the company is advancing precision radiation measurement solutions that support improved treatment verification and clinical outcomes in radiation oncology.
About Standard Imaging, Inc.
Standard Imaging is a global leader in radiation therapy quality assurance, providing advanced technologies that help ensure treatment accuracy, operational efficiency, and patient safety. Trusted by clinics around the world, the company’s comprehensive portfolio of QA solutions enables teams to simplify complex workflows, strengthen clinical confidence, and deliver high-quality patient care. Driven by innovation and a dedication to customer success, Standard Imaging continues to shape the future of QA in radiation oncology.
Media Contact
Bradley Tvedt
MOSkin USA Corporation
Phone: +1 425-417-5521
Email: br********@***************bs.com
Website: moskin-dosimetry.com
Ashley Reis
Standard Imaging
Email: ar***@*************ng.com
Phone: +1 608-824-7873
Website: standardimaging.com